4SC AG
4SC AG: Chairman of the Management Board Enno Spillner will not extend his current term of office, but will leave the Company after a transitional period ending 30 June 2016
4SC AG / Key word(s): Change of Personnel 24.03.2016 09:57 Dissemination of an Ad-hoc-update according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Dissemination of an ad hoc announcement according to § 15 WpHG Chairman of the Management Board Enno Spillner will not extend his current term of office, but will leave the Company after a transitional period ending 30 June 2016 Planegg-Martinsried, Germany, March 24, 2016 - The Chairman of the Management Board of 4SC AG (4SC, FSE Prime Standard: VSE), Enno Spillner, informed 4SC's Supervisory Board today that he will not accept the recently received offer to extend his current term of office ending 31 March 2016. However, Enno Spillner will continue to be at the Company's disposal as Chairman of the Management Board for a transitional period ending 30 June 2016. 4SC's Supervisory Board thanks Enno Spillner for more than 10 years of valuable Management Board service and his sustained engagement for the Company. End of ad hoc release 4SC AG Corporate Communciations & Investor Relations Wolfgang Güssgen, wolfgang.guessgen@4sc.com, +49 89 700763-73 Dr. Anna Niedl, anna.niedl@4sc.com, +49 89 700763-66 MC Services Katja Arnold, katja.arnold@mc-services.eu, +49 89 210228-40 The Trout Group Chad Rubin, crubin@troutgroup.com, +1 646 378 2947 --------------------------------------------------------------------------- Information and Explanation of the Issuer to this News: Dr Clemens Doppler, Chairman of the Supervisory Board of 4SC, comments: 'Enno Spillner's decision is to my very regret, and in the name of the entire Supervisory Board I would like to thank him explicitly for his valuable contributions to the Company and his sustained engagement. Especially over the last three years in which he has been responsible in a CEO / CFO double role, his activities have been instrumental to the advancement of the Company, especially his achievements related to the strategic repositioning and to a successful capital increase. We wish Enno Spillner all the best for his future.' About 4SC 4SC (www.4sc.com) is a biotechnology company dedicated to the research and development of small-molecule drugs focused on epigenetic mechanisms of action for the treatment of cancers with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious than existing therapies, provide a better quality of life and offer increased life expectancy. The Company's pipeline comprises promising products that are in various stages of clinical development. 4SC's aim is to generate future growth and enhance its enterprise value by entering into partnerships with pharmaceutical and biotech companies. Founded in 1997, 4SC had 67 employees (headcount) or 58 full-time equivalents (FTEs) at 31 December 2015. 4SC has been listed on the Prime Standard of the Frankfurt Stock Exchange since December 2005. Forward-looking information This ad hoc release contains certain forward-looking statements. Any forward-looking statement applies only on the date of this ad hoc release. By their nature, forward-looking statements are subject to a number of known and unknown risks and uncertainties that may or may not occur in the future and as a result of which the actual results and performance may differ substantially from the expected future results or performance expressed or implied in the forward looking statements. No warranties or representations are made as to the accuracy, achievement or reasonableness of such statements, estimates or projections, and 4SC AG has no obligation to update any such information or to correct any inaccuracies herein or omission herefrom which may become apparent. 24.03.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: 4SC AG Am Klopferspitz 19a 82152 Martinsried Germany Phone: +49 (0)89 7007 63-0 Fax: +49 (0)89 7007 63-29 E-mail: public@4sc.com Internet: www.4sc.de ISIN: DE000A14KL72 WKN: A14KL7 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Aktuelle News
Aktuelle Berichte
Anstehende Events
Keine Events gefunden